Bracco Diagnostics, Inc: Clinical Trials

14 trials sponsored by Bracco Diagnostics, Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 terminated, 1 recruiting. 14 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 314Completed 9, Terminated 4, Recruiting 1

Follow Bracco Diagnostics, Inc: new trials by email

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lumason® Infusion vs. Bolus Administrations
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON], Lumason - Heart Diseases
Phase 3RecruitingBracco Diagnostics, Inc1062024-07-102026-10-20
CEUS Evaluation of Hypoxic Ischemic Injury
Sulfur hexafluoride lipid-type A microspheres - Hypoxic-Ischemic Encephalopathy, Brain Ischemia Hypoxia
Phase 3CompletedChildren's Hospital of Philadelphia12020-12-012025-05-14
CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis
Sulfur hexafluoride lipid-type A microspheres - Necrotizing Enterocolitis of Newborn, Bowel Ischemic
Phase 3TerminatedChildren's Hospital of Philadelphia12020-11-042024-11-12
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
Lumason - Coronary Artery Disease
Phase 3CompletedBracco Diagnostics, Inc1742015-10-122021-07-07
Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
sulphur hexafluoride lipid-type A microspheres - Heart Disease
Phase 3TerminatedBracco Diagnostics, Inc132015-10-012020-07-13
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
Lumason - Coronary Artery Disease
Phase 3CompletedBracco Diagnostics, Inc1752015-09-242021-06-11
SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization
SonoVue® - Liver Neoplasms
Phase 3CompletedBracco Diagnostics, Inc3532010-06-012018-08-03
SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization
SonoVue-enhanced ultrasound, Unenhanced ultrasound - Liver Neoplasms
Phase 3CompletedBracco Diagnostics, Inc3492009-09-012017-12-12
Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries
Gadobenate Dimeglumine, Gadopentetate Dimeglumine - Carotid, Aortic, Renal or Peripheral Artery Disease
Phase 3CompletedBracco Diagnostics, Inc1202009-09-012012-01-05
SonoVue Guided Prostate Biopsy
Contrast-enhanced ultrasound guided biopsy, ultrasound guided systematic biopsy - Prostate Cancer
Phase 3TerminatedBracco Diagnostics, Inc2822009-02-012012-04-25
Multihance Versus Magnevist in Breast MRI
Multihance, Magnevist - Breast Cancer
Phase 3CompletedBracco Diagnostics, Inc1302007-07-012010-07-15
Crossover Study With MultiHance vs a Comparator for Peripheral MRA
MultiHance, Magnevist - Peripheral Vascular Disease
Phase 3CompletedBracco Diagnostics, Inc1002006-12-012009-03-27
Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent
Multihance, vasovist - Steno-occlusive Disease
Phase 3CompletedBracco Diagnostics, Inc392006-12-012023-08-01
Safety and Efficacy of MultiHance in Pediatric Patients
gadobenate dimeglumine - Central Nervous System Diseases
Phase 3TerminatedBracco Diagnostics, Inc922006-04-012010-10-22

Conditions studied

Coronary Artery Disease (2)  ·  Heart Diseases (2)  ·  Liver Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Central Nervous System Diseases (1)  ·  Hypoxia-Ischemia, Brain (1)  ·  Neoplasms (1)  ·  Peripheral Arterial Disease (1)  ·  Peripheral Vascular Diseases (1)  ·  Prostatic Neoplasms (1)

Interventions

gadobenic acid (5)  ·  contrast agent BR1 (4)  ·  Gadolinium DTPA (3)  ·  Suspensions (1)  ·  gadofosveset trisodium (1)

Countries

United States (9)  ·  Italy (5)  ·  Belgium (2)  ·  Canada (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  China (1)  ·  France (1)  ·  Netherlands (1)

Top investigators

Gianpaolo Pirovano, MD (3)  ·  Melda Dolan, MD (2)  ·  Alberto Spinazzi, M.D. (1)  ·  Gianpaolo Pirovano, M.D. (1)  ·  Jose Banchs, MD (1)  ·  Maria L Storto, MD (1)  ·  Maria Luigia Storto, M.D. (1)  ·  Melda Dolan, M.D. (1)  ·  Misun Hwang, MD (1)

Results publications

PMID 30808770, PMID 21163915, PMID 23042922